GPX2 and lip and oral cavity carcinoma: Likewise, overexpression of an NRF2 target, GPX2, in a different mouse model of oral cancer results in M2 skewing and an increase in myeloid-derived suppressors but with a reduction in T-cell infiltration (14, 34).